Evaluation of contact between lactoferrine level and serum CA 15-3, CEA in patients with breast cancer
Abstract
Milk cancer is one of the most important problems of clinical oncology and occupies the first place in the structure of malignant tumors among women in the world. The most important step in the successful treatment of oncological diseases is their early detection. In recent years, due to the use of modern laboratory-diagnostic methods in clinical practice, results have been achieved in detecting tumor diseases.
References
Berruti A, Tampellini M, Torta M, Buniva T, Gorzegno G, Dogliotti L. Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease. Eur J Cancer. 1994;30A(14):2082–2084.
Bombardieri E, Pizzichetta M, Veronesi P, Seregni E, Bogni A, Maffioli L, Jotti GS, Bassetto MA, Zurrida S, Costa A. CA 15.3 determination in patients with breast cancer: clinical utility for the detection of distant metastases. Eur J Cancer. 1992;29A(1):144–146.
Chlebowski RT, Lillington LM. A decade of breast cancer clinical investigation: results as reported in the Program/Proceedings of the American Society of Clinical Oncology. J Clin Oncol. 1994 Sep;12(9):1789–1795.
Clark GM, Sledge GW, Jr, Osborne CK, McGuire WL. Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol. 1987 Jan;5(1):55–61.
Clavel M, Catimel G. Breast cancer: chemotherapy in the treatment of advanced disease. Eur J Cancer. 1993;29A(4):598–604.
Colomer R, Ruibal A, Salvador L. Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease. Cancer. 1989 Oct 15;64(8):1674–1681.
de Wit R, Hoek FJ, Bakker PJ, Veenhof CH. A comparison of CA-549 with CA 15-3 and MCA in patients with metastatic breast cancer. Ann Oncol. 1992 Apr;3(4):314–315.
Dogliotti L, Berruti A, Buniva T, Zola P, Baù MG, Farris A, Sarobba MG, Bottini A, Alquati P, Deltetto F, et al. Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial. J Clin Oncol. 1996 Apr;14(4):1165–1172.
Keywords
breast cancer
oncological diseases грудь
рак груди
онкологические заболевания süd vəzisi
süd vəzisi xərçəngi
onkoloji xəstəliklər